243 related articles for article (PubMed ID: 28652146)
21. Downregulation of miR-101 contributes to epithelial-mesenchymal transition in cisplatin resistance of NSCLC cells by targeting ROCK2.
Ye Z; Yin S; Su Z; Bai M; Zhang H; Hei Z; Cai S
Oncotarget; 2016 Jun; 7(25):37524-37535. PubMed ID: 27229528
[TBL] [Abstract][Full Text] [Related]
22. MiRNA-26a Contributes to the Acquisition of Malignant Behaviors of Doctaxel-Resistant Lung Adenocarcinoma Cells through Targeting EZH2.
Chen J; Xu Y; Tao L; Pan Y; Zhang K; Wang R; Chen LB; Chu X
Cell Physiol Biochem; 2017; 41(2):583-597. PubMed ID: 28214878
[TBL] [Abstract][Full Text] [Related]
23. mir-126-5p Promotes Cisplatin Sensitivity of Non-Small-Cell Lung Cancer by Inhibiting ADAM9.
Liu B; Wang R; Liu H
Biomed Res Int; 2021; 2021():6622342. PubMed ID: 34055989
[TBL] [Abstract][Full Text] [Related]
24. Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C.
Chang TH; Tsai MF; Gow CH; Wu SG; Liu YN; Chang YL; Yu SL; Tsai HC; Lin SW; Chen YW; Kuo PY; Yang PC; Shih JY
Cancer Lett; 2017 Aug; 402():190-202. PubMed ID: 28610956
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-200c inhibits epithelial-mesenchymal transition, invasion, and migration of lung cancer by targeting HMGB1.
Liu PL; Liu WL; Chang JM; Chen YH; Liu YP; Kuo HF; Hsieh CC; Ding YS; Chen WW; Chong IW
PLoS One; 2017; 12(7):e0180844. PubMed ID: 28727734
[TBL] [Abstract][Full Text] [Related]
26. Loss of Par3 promotes lung adenocarcinoma metastasis through 14-3-3ζ protein.
Song T; Tian X; Kai F; Ke J; Wei Z; Jing-Song L; Si-Hua W; Jian-Jun W
Oncotarget; 2016 Sep; 7(39):64260-64273. PubMed ID: 27588399
[TBL] [Abstract][Full Text] [Related]
27. PKCζ, MMP‑2 and MMP‑9 expression in lung adenocarcinoma and association with a metastatic phenotype.
Cai X; Zhu H; Li Y
Mol Med Rep; 2017 Dec; 16(6):8301-8306. PubMed ID: 28983601
[TBL] [Abstract][Full Text] [Related]
28. Shikonin Inhibited Migration and Invasion of Human Lung Cancer Cells via Suppression of c-Met-Mediated Epithelial-to-Mesenchymal Transition.
Hsieh YS; Liao CH; Chen WS; Pai JT; Weng MS
J Cell Biochem; 2017 Dec; 118(12):4639-4651. PubMed ID: 28485480
[TBL] [Abstract][Full Text] [Related]
29. miR‑181b‑5p mediates TGF‑β1-induced epithelial-to-mesenchymal transition in non-small cell lung cancer stem-like cells derived from lung adenocarcinoma A549 cells.
Li X; Han J; Zhu H; Peng L; Chen Z
Int J Oncol; 2017 Jul; 51(1):158-168. PubMed ID: 28534939
[TBL] [Abstract][Full Text] [Related]
30. FOXC2 promotes epithelial-mesenchymal transition and cisplatin resistance of non-small cell lung cancer cells.
He Y; Xie H; Yu P; Jiang S; Wei L
Cancer Chemother Pharmacol; 2018 Dec; 82(6):1049-1059. PubMed ID: 30302523
[TBL] [Abstract][Full Text] [Related]
31. PKCζ Promotes Breast Cancer Invasion by Regulating Expression of E-cadherin and Zonula Occludens-1 (ZO-1) via NFκB-p65.
Paul A; Danley M; Saha B; Tawfik O; Paul S
Sci Rep; 2015 Jul; 5():12520. PubMed ID: 26218882
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of CXCR4 regulates epithelial mesenchymal transition of NSCLC via the Hippo-YAP signaling pathway.
Zheng CH; Chen XM; Zhang FB; Zhao C; Tu SS
Cell Biol Int; 2018 Sep; 42(10):1386-1394. PubMed ID: 29972256
[TBL] [Abstract][Full Text] [Related]
33. Increased sensitivity of human lung adenocarcinoma cells to cisplatin associated with downregulated contactin-1.
Zhang R; Yao W; Qian P; Li Y; Jiang C; Ao Z; Qian G; Wang C; Wu G; Li J; Ji F; Xu J
Biomed Pharmacother; 2015 Apr; 71():172-84. PubMed ID: 25960233
[TBL] [Abstract][Full Text] [Related]
34. Benzo(a)pyrene regulated A549 cell migration, invasion and epithelial-mesenchymal transition by up-regulating long non-coding RNA linc00673.
Wu Y; Niu Y; Leng J; Xu J; Chen H; Li H; Wang L; Hu J; Xia D; Wu Y
Toxicol Lett; 2020 Mar; 320():37-45. PubMed ID: 31778776
[TBL] [Abstract][Full Text] [Related]
35. Apical-basal polarity inhibits epithelial-mesenchymal transition and tumour metastasis by PAR-complex-mediated SNAI1 degradation.
Jung HY; Fattet L; Tsai JH; Kajimoto T; Chang Q; Newton AC; Yang J
Nat Cell Biol; 2019 Mar; 21(3):359-371. PubMed ID: 30804505
[TBL] [Abstract][Full Text] [Related]
36. [SP13786 Inhibits the Migration and Invasion of Lung Adenocarcinoma Cell A549
by Supressing Stat3-EMT via CAFs Exosomes].
Wang S; Cui J; Zhang K; Gu J; Zheng Y; Zhang B; Shi L
Zhongguo Fei Ai Za Zhi; 2021 Jun; 24(6):384-393. PubMed ID: 34024061
[TBL] [Abstract][Full Text] [Related]
37. Duchesnea indica extract suppresses the migration of human lung adenocarcinoma cells by inhibiting epithelial-mesenchymal transition.
Chen PN; Yang SF; Yu CC; Lin CY; Huang SH; Chu SC; Hsieh YS
Environ Toxicol; 2017 Aug; 32(8):2053-2063. PubMed ID: 28371048
[TBL] [Abstract][Full Text] [Related]
38. Gli promotes epithelial-mesenchymal transition in human lung adenocarcinomas.
Li H; Yue D; Jin JQ; Woodard GA; Tolani B; Luh TM; Giroux-Leprieur E; Mo M; Chen Z; Che J; Zhang Z; Zhou Y; Wang L; Hao X; Jablons D; Wang C; He B
Oncotarget; 2016 Dec; 7(49):80415-80425. PubMed ID: 27533453
[TBL] [Abstract][Full Text] [Related]
39. The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells.
Guo J; Jin D; Wu Y; Yang L; Du J; Gong K; Chen W; Dai J; Miao S; Xi S
EBioMedicine; 2018 Sep; 35():204-221. PubMed ID: 30146342
[TBL] [Abstract][Full Text] [Related]
40. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
